Thyroid disorder decisions — 2025

The Board remands the claim for service connection for hypothyroidism as it is inextricably intertwined with the pending claim for laryngectomy with benign or malignant neoplasm.

The Board granted service connection for a thyroid disability, to include multinodular goiter and malignant tumor of the thymus status post total thyroidectomy with secondary hypothyroidism as secondary to Hodgkin's disease, nodular sclerosing type, blast rich and thymoma, and also granted service connection for a neck scar associated with this thyroid disability.

The Board remands the claim for service connection for thyroid cancer with residuals of thyroidectomy to have the Under Secretary for Health prepare a dose estimate as required under 38 C.F.R. § 3.311(a)(2)(iii).

The Board granted an effective date of January 8, 2021, for the grant of service connection for hypothyroidism associated with herbicide exposure.

The Board remands the claims for service connection for hypothyroidism and to determine whether the withholding of VA disability compensation to recoup severance pay was proper.

The Board denied an initial rating in excess of 30 percent for hypothyroidism and granted a total disability rating based on individual unemployability (TDIU) from October 1, 2014.

The Board remands the matter for additional development and readjudication to determine whether the Veteran has had a thyroid disability that began during or is related to service.

The Board remands the claim for service connection for hypothyroidism to obtain an adequate medical opinion regarding the Veteran's exposure to AFFF and other toxic substances during service.

The Board granted service connection for hypothyroidism, finding that new and relevant evidence had been submitted linking the condition to herbicide exposure during the Veteran's service in Vietnam.

The Board granted service connection for female sexual arousal disorder (FSAD) and denied service connection for chronic fatigue syndrome, sinusitis, a compensable rating for rhinitis, a compensable rating for hypothyroidism, and a rating in excess of 50 percent for obstructive sleep apnea with asthma and chronic bronchitis.

The Board granted an initial rating of 60 percent for service-connected CAD and denied increased ratings for other conditions.

The Board denied service connection for asthma and granted higher initial ratings, earlier effective dates, or SMC in some cases while denying them in others.

The Board remands the claim for service connection of hyperparathyroidism to correct a duty to assist error, requiring an adequate medical opinion regarding its relation to military service.

The Board denied service connection for various disabilities, including right knee, left knee, right wrist, right foot, soft tissue sarcoma, thyroid disorder, and right hand disability.

The Board dismissed the claims for service connection for an acquired psychiatric disorder, claimed as anxiety and PTSD; a back injury; right knee, Osgood Schlatter condition; and thyroid nodular disease, non-malignant due to the rule against concurrent election.

The appeal for service connection for a back disability and neck disability was dismissed as moot, with full benefits granted. Other claims were remanded for further review.

The Board denied service connection for obstructive sleep apnea, headaches, erectile dysfunction, and hypertension. However, it granted service connection for irritable bowel syndrome and hypothyroidism.

The Board granted service connection for low back and right shoulder conditions based on new and relevant evidence, but denied service connection for hypothyroidism.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board remands the claim for a new VA examination to address whether the Veteran's mental health conditions and eye conditions are attributable to his hypothyroidism.